There are several different GLP-1 agonists, with Ozempic, Wegovy, Zepbound, and Mounjaro being popular choices
Morbidity improvements are generally lower than mortality improvements due to a higher proportion of morbidity incidence (in a critical illness product) being caused by cancers (where the relative risks of incidence by BMI are lower), compared to mortality, with a higher proportion of deaths caused by CVD (where the relative risks by BMI are higher)
People with certain health issues should not take them
10.3389/fgene.2020.00928 139 HadanoS.OtomoA.KunitaR.Suzuki-UtsunomiyaK.AkatsukaA.KoikeM.et al
He also had an early addiction to money, which became an addiction to feeling important
Currently, there are no large-scale clinical trials specifically designed to evaluate GLP-1 medications for joint pain or osteoarthritis treatment